Akari Therapeutics Appoints Former AACR President and Renowned Oncology Drug Development Leader, Patricia LoRusso, D.O., to Scientific Advisory Board

Detailed price information for Akari Therapeutics ADR (AKTX-Q) from The Globe and Mail including charting and trades.
Technology Networks

Redefining Early Oncology R&D: What ASCO 2026 Reveals About the Future of Precision-Driven Development

ASCO 2026 highlighted a shift toward precision-driven oncology R&D, where biomarkers, ctDNA, and integrated strategies guide ...

Systemic Lupus Erythematosus Market at a Turning Point as 6 Late-Stage Emerging Therapies Set to Redefine Treatment Landscape | DelveInsight

Systemic lupus erythematosus (SLE) is a chronic, complex autoimmune disease that can affect multiple organ systems, with ...
Electronic Design

Why Communications Systems are Migrating to ASIC Architectures

Next-gen comms platforms are shifting from FPGAs to ASIC-based architectures. How does custom silicon deliver major gains in ...
Frontiers

Natural products, immune modulation and cancer: Mechanisms and therapeutic potential

Cancer is one of the leading causes of death globally, with increasing numbers in incidence and mortality. Cancer incidence is projected to increase by 70% ...
Frontiers

Flipping the Immune Switch: Small-Molecule and Biologic Pharmacology to Convert the Immunosuppressive Tumor Microenvironment into an Immunoreactive One

The tumor microenvironment (TME) is one of the most formidable barriers to durable cancer immunotherapy. Far from being a passive bystander, the TME ...